The Multiple Sclerosis Impact Scale (MSIS-29)A new patient-based outcome measure
TLDR
Results indicate the MSIS-29 is a clinically useful and scientifically sound patient-based outcome measure of the impact of multiple sclerosis suitable for clinical trials and epidemiological studies.Abstract:
Changes in health policy have underlined the importance of evidence-based clinical practice and rigorous evaluation of patient-based outcomes. As patient-based outcome measurement is particularly important in treatment trials of multiple sclerosis, a number of disease-specific instruments have been developed recently. One limitation of these instruments is that none was developed using the standard psychometric approach of reducing a large item pool generated from people with multiple sclerosis. Consequently, an outcome measure for clinical trials of multiple sclerosis that is disease specific and combines patient perspective with rigorous psychometric methods will complement existing instruments. The aim of this study was to develop such a measure. Standard psychometric methods were used. A pool of 129 questionnaire items was generated from interviews with 30 people with multiple sclerosis, expert opinion and literature review. The questionnaire was administered by postal survey to 1530 people selected randomly from the Multiple Sclerosis Society membership database. Redundant items and those with limited measurement properties were removed. The remaining items (n = 41) were grouped into scales using factor analysis, and then refined to form the Multiple Sclerosis Impact Scale (MSIS-29), an instrument measuring the physical (20 items) and psychological (nine items) impact of multiple sclerosis. Five psychometric properties of the MSIS-29 (data quality, scaling assumptions, acceptability, reliability and validity) were examined in a separate postal survey of 1250 Multiple Sclerosis Society members. A preliminary responsiveness study of the MSIS-29 was undertaken in 55 people admitted for rehabilitation and intravenous steroid treatment of relapses. The MSIS-29 satisfied all psychometric criteria. Data quality was excellent, missing data were low (maximum 3.9%), item test-re-test reliability was high (r = 0.65-0.90) and scale scores could be generated for >98% of respondents. Item descriptive statistics, item convergent and discriminant validity, and factor analysis indicated that it was legitimate to generate scores for MSIS-29 scales by summing items. MSIS-29 scales showed good variability, small floor and ceiling effects, high internal consistency (Cronbach's alpha <or=0.91) and high test-re-test reliability (intraclass correlation <or=0.87). Correlations with other measures and the analysis of group differences provided evidence that the MSIS-29 measures the physical and psychological impact of multiple sclerosis. Effect sizes (physical scale = 0.82, psychological scale = 0.66) demonstrated preliminary evidence of good responsiveness. These results indicate the MSIS-29 is a clinically useful and scientifically sound patient-based outcome measure of the impact of multiple sclerosis suitable for clinical trials and epidemiological studies.read more
Citations
More filters
Journal ArticleDOI
Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity
Richard Roxburgh,S. R. Seaman,T Masterman,Anke Hensiek,Stephen Sawcer,Sandra Vukusic,Iuliana Achiti,Christian Confavreux,M. Coustans,E. Le Page,Gilles Edan,G V McDonnell,Stanley Hawkins,Maria Trojano,Maria Liguori,Eleonora Cocco,Maria Giovanna Marrosu,Fabiana Tesser,Maurizio Leone,Alexandra Weber,Frauke Zipp,Bianca Miterski,Jörg T. Epplen,Annette Bang Oturai,P. Soelberg Sørensen,Elisabeth Gulowsen Celius,N. Téllez Lara,Xavier Montalban,Pablo Villoslada,Ana Martins da Silva,Monica Marta,Isabel Leite,Bénédicte Dubois,Justin P. Rubio,Helmut Butzkueven,Trevor J. Kilpatrick,Marcin P. Mycko,Krzysztof Selmaj,Maria Edite Rio,Maria José Sá,Giuseppe Salemi,Giovanni Savettieri,Jan Hillert,D. A. S. Compston +43 more
TL;DR: The Multiple Sclerosis Severity Score (MSSS) as mentioned in this paper measures the severity of a patient with multiple sclerosis using the Expanded Disability Status Scale (EDSS) score.
Journal ArticleDOI
Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12).
TL;DR: The 12-Item MS Walking Scale satisfies standard criteria as a reliable and valid patient-based measure of the impact of MS on walking and was more responsive than other walking-based scales.
Journal Article
The multiple sclerosis severity score
TL;DR: The Multiple Sclerosis Severity Score (MSSS) is a powerful method for comparing disease progression using single assessment data and can be used as a reference table for future disability comparisons.
Journal ArticleDOI
Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology.
Sarah Smith,Donna L. Lamping,Sube Banerjee,Rowan H. Harwood,B Foley,Peter C. Smith,J. Cook,Joanna Murray,Martin Prince,Enid Levin,Anthony Mann,Martin Knapp +11 more
TL;DR: The DEMQOL system has been validated in the UK in a large sample of people with dementia and their carers, and it provides separate measures for self-report and proxy report, which allows outcomes assessment across a wide range of severity in dementia.
Journal ArticleDOI
Primary-progressive multiple sclerosis
TL;DR: MRI of the brain and spinal cord, and examination of the CSF, are important investigations for diagnosis; conventional immunomodulatory therapies, such as interferon beta and glatiramer acetate, are ineffective.
References
More filters
Book
Statistical Power Analysis for the Behavioral Sciences
TL;DR: The concepts of power analysis are discussed in this paper, where Chi-square Tests for Goodness of Fit and Contingency Tables, t-Test for Means, and Sign Test are used.
Journal ArticleDOI
Coefficient alpha and the internal structure of tests.
TL;DR: In this paper, a general formula (α) of which a special case is the Kuder-Richardson coefficient of equivalence is shown to be the mean of all split-half coefficients resulting from different splittings of a test, therefore an estimate of the correlation between two random samples of items from a universe of items like those in the test.
Journal ArticleDOI
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
John E. Ware,Cathy D. Sherbourne +1 more
TL;DR: A 36-item short-form survey designed for use in clinical practice and research, health policy evaluations, and general population surveys to survey health status in the Medical Outcomes Study is constructed.
Journal ArticleDOI
Rating neurologic impairment in multiple sclerosis An expanded disability status scale (EDSS)
TL;DR: A new Expanded Disability Status Scale (EDSS) is presented, with each of the former steps (1,2,3 … 9) now divided into two (1.0, 1.5, 2.0 … 9).
Journal ArticleDOI
The scree test for the number of factors
TL;DR: The Scree Test for the Number Of Factors this paper was first proposed in 1966 and has been used extensively in the field of behavioral analysis since then, e.g., in this paper.